Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report

Mark Steven Miller¹, Peter Allen, Teresa A Brentnall+16

• ¹From the *Division of Cancer Prevention, National Cancer Institute, Bethesda, MD; †Department of Surgery, David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; ‡Division of Gastroenterology, University of Washington at Seattle, Seattle, WA; §Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD; ∥Department of Epidemiology, Health Sciences Research, Mayo Clinic, Rochester, MN; ¶Department of Medicine, Center for Cancer Prevention and Drug Development Program, PC Stephenson Oklahoma Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK; #Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA; **Department of Medicine, Mayo Clinic, Rochester, MN; ††Department of Oncology, National Familial Pancreas Tumor Registry, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD; ‡‡Department of Surgery, Pancreatic Cancer Center, University of Michigan, Ann Arbor, MI; §§Department of Internal Medicine, Pancreatic Cancer Center, University of Michigan, Ann Arbor, MI; ∥∥Department of Surgery, Translational Oncology Program, Pancreatic Cancer Center, University of Michigan, Ann Arbor, MI; and ¶¶Department of Medicine, Pancreatic Tumor Center, Dana-Farber Cancer Institute, Harvard Medical School, Cambridge, MA.